HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.

AbstractBACKGROUND:
Vasopressin is known to be an effective vasopressor in the treatment of septic shock, but uncertainty remains about its effect on other hemodynamic parameters.
METHODS:
We examined the cardiopulmonary effects of vasopressin compared with norepinephrine in 779 adult patients with septic shock recruited to the Vasopressin and Septic Shock Trial. More detailed cardiac output data were analyzed for a subset of 241 patients managed with a pulmonary artery catheter, and data were collected for the first 96 h after randomization. We compared the effects of vasopressin vs norepinephrine in all patients and according to severity of shock (< 15 or ≥ 15 μg/min of norepinephrine) and cardiac output at baseline.
RESULTS:
Equal BPs were maintained in both treatment groups, with a significant reduction in norepinephrine requirements in the patients treated with vasopressin. The major hemodynamic difference between the two groups was a significant reduction in heart rate in the patients treated with vasopressin (P <.0001), and this was most pronounced in the less severe shock stratum (treatment × shock stratum interaction, P =.03). There were no other major cardiopulmonary differences between treatment groups, including no difference in cardiac index or stroke volume index between patients treated with vasopressin and those treated with norepinephrine. There was significantly greater use of inotropic drugs in the vasopressin group than in the norepinephrine group.
CONCLUSIONS:
Vasopressin treatment in septic shock is associated with a significant reduction in heart rate but no change in cardiac output or other measures of perfusion.
TRIAL REGISTRY:
ISRCTN Register; No.: ISRCTN94845869; URL: www.isrctn.org
AuthorsAnthony C Gordon, Nan Wang, Keith R Walley, Deborah Ashby, James A Russell
JournalChest (Chest) Vol. 142 Issue 3 Pg. 593-605 (Sep 2012) ISSN: 1931-3543 [Electronic] United States
PMID22518026 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Vasoconstrictor Agents
  • Vasopressins
  • Norepinephrine
Topics
  • Adult
  • Aged
  • Blood Pressure (drug effects, physiology)
  • Cardiac Output (drug effects, physiology)
  • Cardiovascular System (drug effects, physiopathology)
  • Double-Blind Method
  • Female
  • Heart Rate (drug effects, physiology)
  • Hemodynamics (drug effects, physiology)
  • Humans
  • Male
  • Middle Aged
  • Norepinephrine (pharmacology, therapeutic use)
  • Severity of Illness Index
  • Shock, Septic (drug therapy, physiopathology)
  • Stroke Volume (drug effects, physiology)
  • Vasoconstrictor Agents (pharmacology, therapeutic use)
  • Vasopressins (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: